Actinium Pharmaceuticals
ATNM
ATNM
41 hedge funds and large institutions have $23.1M invested in Actinium Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
31% less funds holding
Funds holding: 59 → 41 (-18)
62% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 29
Holders
41
Holding in Top 10
–
Calls
$1.35M
Puts
$498K
Top Buyers
| 1 | +$940K | |
| 2 | +$559K | |
| 3 | +$557K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$461K |
| 5 |
Bank of New York Mellon
New York
|
+$412K |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$1.27M | |
| 3 | -$1M | |
| 4 |
BlackRock
New York
|
-$992K |
| 5 |
SCM
Sio Capital Management
New York
|
-$800K |